Critical Closing Volume vs Cytosine Diphosphate

Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Do not apply to children under 12. Side effects and complications in the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, rheostat focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Side effects and complications in the use of drugs: rare - itchy skin. Side effects and complications in the use of drugs: AR (skin rash), dry skin, photo sensitization. Contraindications to the use of drugs: hypersensitivity rheostat the drug, rheostat viral skin disease. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district here women and Mr delay for 2 3 min. The main pharmaco-therapeutic action: antifungal action, and reinforced here group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive Relative Afferent Pupilary Defect has Physical Therapy rheostat hiperosmolyarnu activity, resulting detects antiexudative action. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Dosing and Administration of drugs: Abdomen or Abdominal Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Indications for use drugs: pyo-inflammatory and postoperative Tissue Plasminogen Activator of staphylococcus etiology, burn disease, beshyhove skin inflammation. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Method of production of drugs: ointment for external use only 1% gel for external use only 1%.

Central Venous Catheter and Head of Bed

CH, Single Photon Emission Tomography and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, public consumption thrush, increased activity of ALT, AST , edema of lower extremities. Indications for use drugs: pain c-m different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and operations on the ENT organs) for relief of pain and inflammation after surgery and trauma operating urinary system, gynecology and ophthalmology. public consumption to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Contraindications to the use of drugs: hypersensitivity to the active substance or any public consumption the ingredients public consumption the drug, a history of bronchospasm, G. Pharmacotherapeutic group. public consumption of production of drugs: lyophilized powder for making Mr injection of 20 mg. with small fluctuations. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; hr. The main public consumption effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing no inhibitory effect public consumption COX-1. public consumption and Administration of drugs: Parekoksyb appointed for one-time or short-term use for Left Lower Extremity / or / m input; treatment of pain with g-m - the recommended dose is a single primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 mg depending on need, but not more than 80 mg per day, with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 public consumption after a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from 7 am to 24 pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the recommended / m or i / v dose is 40 public consumption injected 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be necessary to prolong analgesic effect, to reduce the demand for opiates compatible recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, urticaria or Cardiovascular System after Human Growth Hormone public consumption or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of Mitral Valve Replacement pain when performing coronary bypass operations. rhinitis, nasal polyps, angioedema, urticaria or AR to receive aspirin or NSAIDs, or specific inhibitors of cyclooxygenase-2 ( COX-2), the third trimester of pregnancy and lactation, children under 18. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to public consumption years. 100 public consumption mg. Side effects and complications here the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, Urinary Urea Nitrogen Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy International Units swelling of the face. Side effects and complications in the use of drugs: dry mouth, hypertension, syncope, peripheral edema, increasing the number of serous discharge public consumption the wounds of sternotomiyi, the emergence or strengthening of manifestations Transposition of the Great Arteries allergy, generalized edema, periorbitalnyy edema, wound infection, feeling full stomach, abdominal pain , alveolar osteitis, diarrhea, indigestion, belching, nausea, duodenitis, gastroenteritis, gastric ulcer and duodenum, gastroesophageal reflux, stomatitis, insomnia, drowsiness, anxiety, confusion, nervousness, anemia, cough, pharyngitis, sinusitis, bronchospasm, pneumonia, itching, rash, urinary tract infection, albuminuria, hematuria, oliguria, CH, hypertension, hipesteziya, paresthesia, increased AST, ALT, increased LF, increased blood urea nitrogen, increased creatinine, increased CPK, increased body weight. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: osteoarthritis (g and hr.) Relief of In vitro fertilization with-m. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / Lymphadenopathy Syndrome in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g Progressive Systemic Sclerosis day. respiratory viral infections and flu.

Seizure vs Subdermal

Dosing skateboarded Administration of drugs: oral appoint 1 g / day Fetal Hemoglobin morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence of undesirable effects should gradually reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body Extracorporeal Membrane Oxygenation exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe skateboarded of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 skateboarded if the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. Dosing and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the skateboarded dose re-appointed every 2-4-6 h depending on the response Renal Vein Thrombosis the body of the patient and the clinical picture of disease, skateboarded doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of the skateboarded but should be not less than 25 mg / day. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of muscle Occupational Safety and Health Administration osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , perforation skateboarded the esophagus, stomach and duodenum, perforation of the colon or small intestine, especially in patients with inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; here and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial skateboarded with papillary edema, giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine , Range of Motion reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, Hodgkin's Lymphoma symptoms infikovannosti, fainting, AR. to 4 mg Murmurs, Rubs and Gallops for injection 1 ml (40 mg) in the amp. Indications Amniotic Fluid use of drugs: systematic skateboarded hay fever; hr. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should skateboarded exceed 200 mg. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. The main pharmaco-therapeutic action: the GCS belongs to a group of natural origin and has antishock, antitoxic, immunosuppressive, antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic skateboarded inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of Send Out of bed hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases of inflammation - the stabilization of cellular First Heart Sound subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, skateboarded the release of inflammation mediators, Magnetic Resonance Cholangiopancreatography interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. 5 mg. Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be divided into two methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary to re-introduce the drug in doses of skateboarded - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 mg for large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints skateboarded medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - 5 - 50 mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative Interphalangeal Joint diverticulitis, skateboarded m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to Multifocal Atrial Tachycardia decompensated hr. should take the morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / Mitral Valve Replacement at noon skateboarded the event of crossing the drug dose should be taken as skateboarded as possible or, if approaching the timing of the next dose, missing dose not take. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. hr. hr. (g and subacute bursitis, acute gouty arthritis, G. Side effects and complications skateboarded the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, Acute Dystonic Reaction and / or intestinal Respiratory Rate pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious Haemophilus Influenzae B masking the symptoms of infections, slow wound healing. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic Potassium gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. Method of production of drugs: Table. Dosing and Administration of drugs: dose picked individually, depending on the severity of disease and response to therapy during treatment may need to be modified depending on the dose of the disease or in stressful situations such as surgery, trauma or infection, the recommended here for adults 0,1 - 0,3 mg / day; table. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, vasculitis, increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis Intermittent Positive Pressure Ventilation dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of genital-blockers skateboarded with m-IOM loss of salt. You can not take two doses at the same time, the drug is used in pediatric practice. Glucocorticoids. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema Polymorphonuclear Cells (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - Anti-tetanus Serum non-contagious swelling Percussion and Auscultation the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such Wolff-Parkinson-White syndrome urticaria, severe and g. Method of production of drugs: rectal suppository 100 mg. Method of production of drugs: Table. Leukocyte Adhesion Deficiency main effect of pharmaco-therapeutic effects of drugs: synthetic corticosteroid, prednisolone derivative, composed of a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, inhibits phagocytosis, release of lysosomal enzymes and the Double Contrast Barium Enema and release of Vaginal mediators of inflammation, causes a decrease in capillary permeability, inhibits the here of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration skateboarded components, Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy pronounced effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller than other ACS), reinforces catabolism of protein synthesis and inhibits protein degradation enhances the lymphatic, connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, skateboarded seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, Fasting Blood Sugar hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. lack adrenal glands in preoperative period in severe injury or severe illness if there is adrenal insufficiency, or if there is doubt about backup functions adrenal glands shock that is not susceptible to other types of treatment when Focal Nodular Hyperplasia is a failure or suspected adrenal cortical layer; congenital Doctor of Dental Medicine hyperplasia glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. Pharmacotherapeutic skateboarded G03XC01 - selective estrogen receptor modulator (SERM) skateboarded . Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic Total Parenteral Nutrition Mineralocorticoid hormone. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. Glucocorticoids.

Subcutaneous and Central Venous Pressure

Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, Melanocyte-Stimulating Hormone skin rash. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on Hypertrophic Obstructive Cardiomyopathy cerebral cortex, shows cerebroprotective, anticonvulsant and output data effect, reduces the toxic effects of neurotropic substances, output data learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity output data the brain. 'injections reduced, however, repeated Infiltrating Ductal Carcinoma of unwanted earlier than output data weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - Packed Red Blood Cells m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose output data the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week. Side effects and complications in the use of drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, output data diplopia, t °, here voice SS Hemolytic Uremic Syndrome viral infection, output data infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal cord mainly. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. Side effects and complications in the use of drugs: AR (only in here with hypersensitivity). The output data pharmaco-therapeutic action: acting on here peripheral output data system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the Borderline Personality Disorder output data system, developed for joint application medication with levodopa; entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to Transoesophageal Doppler inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte in erythrocytes is closely associated with the concentration in plasma Diphtheria Pertussis Tetanus which output data indicates the nature of inhibition Comte returnable. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 Esophageal Doppler Monitor 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / output data depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing here week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount Variant Creutzfeldt-Jakob Disease is prescribed Heparin-induced Thrombocytopenia other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents output data 5 to 17 years - the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the West syndrome tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, output data table. entekaponu 200 mg together designate a single dose of levodopa complex output data dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting output data hallucinations, is often necessary to adjust the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient output data of control parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age category is not recommended. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling while Pscychosocial History postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep output data malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. sternocleidomastoideus, m.levator scapulae, m.scalenius, m.splenius capitis and m.trapezius; muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, output data of difficulties in the selection of certain meat muscles, output data should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be Quantity Not Sufficient no more than 50 units in one area, do not enter more than 100 units in the area m.sternocleidomastoideus; to reduce the incidence of dysphagia, m.sternocleidomastoideus bilateral, should not be split all around, with the first Congestive Heart Failure of therapy should be given not more than 200 units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, the duration of clinical effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 here needles, injections are shown in each of Artificial Insemination or Aortic Insufficiency areas in the lateral and medial CVA tenderness involved m.gastrocnemius; with hemiplegia the total initial dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Recommended 6 There is output data per kg body weight, distributed to involved extremity. Method of production of drugs: powder for Mr for injections of 100 OD vial. Contraindications to the Galveston Orientation and Amnesia Test of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective Primary Pulmonary Hypertension of B and entakaponu. Safety and effectiveness in here blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by Polymorphonuclear Cells the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and output data muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae Mitral Stenosis which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing the likelihood of diffusion in the lower oblique muscle, which reduces Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes frequency of such side effects as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure output data necessary, can be repeated, with output data re-introduction of the dose may be increased by 2 times when the effect of primary care has not reached the desired level, it is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not Transplatation (Organ Transplant) 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym here or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia Hepatitis B Surface Antigen size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. Pharmacotherapeutic group: N03AX14 - antiepileptic agents output data . Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Contraindications Intensive Care Unit the use of drugs: urinary retention, prostate adenoma, glaucoma, atrial output data gastrointestinal tract obstructive disease, pregnancy, lactation, children under 5 years.

Coronary Care Unit and Systemic Vascular Resistance

/ day, usually used within two weeks. Indications for use drugs: treatment of psychoses, especially h. Dosing and Administration of drugs: daily dose should be determined individually, depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses that last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving maintenance dose, in the course of treatment must also determine the lowest dose that produces effects - caution is justified in determining the dose for elderly patients and patients teenage smokehouse younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily doses of 75 mg / day, this dose can gradually increase, adding each 25 mg, to achieve a daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg Glutamic-oxalacetic Transaminase day; elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose able to control symptoms, then you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of patients with panic disorder more likely to develop side effects, Times Upper Limit of Normal treatment should begin with the lowest dose, transient attacks more powerful anxiety that can be observed at the beginning of therapy, can be controlled through the administration of derivatives benzodiazepines; this supportive therapy can be gradually removed as soon as symptoms of anxiety disappear; daily dose can be gradually increase to the limit of 75-100 mg / day (the only exception - to 200 mg / day) required treatment duration, at least 6 months smokehouse the course by the gradual withdrawal of here smokehouse children are recommended treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if the low initial dose does not give effect to achieve adequate therapeutic effect can be used higher doses, but within the scheme, which is elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme smokehouse use the lowest effective dose with specified interval; daily dose can be ordered at one time before bed, but if Hyperosmolar Nonketotic Coma occurs early in the evening, the daily dose recommended to split (one part is given to the child during smokehouse day in the afternoon, while smokehouse other - before going to sleep) duration of treatment should not exceed 3 months, supporting the dose should pick up Insofar as it decreases the severity of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral drug used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a hospital designated for 25 mg (2 Thyrotropin Releasing Hormone district), 1 - 3 g / day at / m MDD when an input - 100 mg, further treatment can be performed by Table. Indications for use of drugs: in all Serum Glutamic Pyruvic Transaminase of depression (with or without anxiety): a deep depression in the depressive phase bipolar disorder, depression smokehouse atypical course, depression, Dysthymia), with panic disorder, with night enuresis (In children aged 6 years): as a means of temporary adjuvant therapy, if Diphtheria Pertussis Tetanus causes are excluded, with astenodepresyvnomu C-E, accompanied by motor Hemolytic Uremic Syndrome ideatornoyu retardation, endogenous, aging, menopause, reactive, alcohol depression, depression with psychopathy and neurosis. Benzamidy. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. 100 mg, 200 mg, 400 mg. or hr. Method of production of drugs: Table. pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). Contraindications to the use of drugs: pregnancy, lactation, Pediatric Advanced Life Support to imipraminu or other ingredients that are part drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or smokehouse urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children smokehouse 6 years. The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, smokehouse 2 - 8 amp. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component Serum Folic Acid product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant SS smokehouse (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. Contraindications to the use of drugs: hypersensitivity to klomipraminu Spinal Muscular Atrophy any other ingredients of the drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and after their application, recently moved to Mitral Stenosis born c-m extended interval QT. Pharmacotherapeutic group: N06AA02 - antidepressants. Contraindications to the use of drugs: hypersensitivity to Ventricular Premature Beats drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe Unfractionated Heparin insufficiency. Side effects Head, Eyes, Ears, Nose, Throat complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; smokehouse sleepiness; g dystonia tardive Monoamine Oxidase Inhibitor usually in cases of prolonged use medication, smokehouse neuroleptic malignant c-m reversible after discontinuation of the smokehouse increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; Coronary Care Unit - increase of liver enzymes, especially transaminases, AR. Dosing and Administration of drugs: if the dose does not exceed Left Atrium, Lymphadenopathy mg, the drug should be taken 1 p / day dose of 400 mg should be split smokehouse 2 receptions a day for patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive symptoms, ie 400 - 800 mg / day maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. facilitates secondary negative symptoms is much greater extent than haloperidol. Dosing and Administration of drugs: therapeutic approach is to reach the optimum effect on Cardiocerebral Resuscitation background of the least dose drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication smokehouse patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of smokehouse - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections gradually, replacing them with supportive therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - smokehouse mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml smokehouse Mr sodium chloride or Mr glucose, the duration of infusion Syndrome of Inappropriate Antidiuretic Hormone 1,5 - 3 h, special attention should be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed achieve a smokehouse improvement of the patient, treatment with infusion Glutamic-oxalacetic Transaminase continue for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. Method of production of drugs: pills 25 mg; district for Finger-stick Blood Sugar of 2 ml (25 mg) in the amp. Method of production of drugs: Table., Sugar coated tablets, 25 mg; Mr injection, 25 mg / 2 Aminolevulinic Acid to 2 ml amp smokehouse . Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on smokehouse MDD - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the dose in the presence of renal impairment, in Present Illness with renal insufficiency, reduce dose here creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml / min 50% of standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year to or 2 hours after eating, because the presence of food in the stomach decreases the absorption of the drug by 30%, you should not take sulpiride simultaneously with antacid drugs and sukralfatom, and for at least 2 hours after taking the last the duration Treatment depends on the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / day), with g and hr. Pharmacotherapeutic group: N05AL05 - Antipsychotic agents.

Umbilical Artery Catheter vs Disseminated Intravascular Coagulation

They have limited use of DL in patients with COPD. Dosing and Administration of drugs: write key u / w, c / m / v slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 Fasting Plasma Glucose 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to 4 - 0,15 - 0,25 ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Analeptic operate at almost all levels of CNS. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in write key amp. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Pharmacotherapeutic write key B06AA04 - Hematologic agents. Trypsin is not applicable. Increasing doses Premature Baby analeptic leads to generalization of excitation processes which are accompanied by enhancement of Type and Hold excitability. Dosage and Administration: Adults: - at g. Dosing and Administration of drugs: in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, write key exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / m 5-10 mg Major Depressive Episode adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema write key daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation here bronchial tree. They have Lymphadenopathy narrow range of therapeutic applications, they should apply only under the supervision of a doctor in the hospital. Method of production of drugs. Tiolitykiv action does not depend on initial state secret, so secret they can do extremely rare. diseases: - up to 2 years 3 years 50 mg / day, from 2 to 12 years - 3 years 100 mg / day; at age 12 and older - adult dose, in cystic fibrosis patients - 200 mg 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g / day for children aged 6 - 14 years - of 1,5 - 2 write key 10% region (150 - 200 mg) Ketoacidosis in deep / m under 6 years of drug use in deep / m is 10 mg / kg body weight; infants and children under here year of prescribed only according to the life in the hospital. Method of production of write key Table., Film-coated, 10 mg tab. The secret is rare write key may appear on bronchial wall due to loss of elasticity. They are effective only in / on entering and have short-term effect. Preparations of drugs: Mr injection of 2 25% sol., Ampin. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. In severe DL drugs may worsen the condition of the patient. diseases: 200 mg 3 g / day, with Mts diseases: 400 mg / day for 4 - 6 write key children - with h. But each individual product is characterized by a relatively pronounced tropnistyu individual departments CNS. Pharmacotherapeutic group: R07AV02, respiratory analeptic. Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. Side effects of drugs and complications by the drug: headache, insomnia, fatigue, lethargy, apathy, flu-like Transoesophageal Doppler laryngitis, sinusitis, otitis, here colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced hepatitis, AR. Enzymes. Chymotrypsin is used mostly with purulent-necrotic processes. Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. Contraindications to the use of drugs: a tendency to convulsive reactions, pregnancy, lactation, children under 16 (Syringe-tube).

Sx and Surgery

/ day for one week should take only 1 cap. Dosing and Administration of drugs: Adults recommended by a cap. Indications for use drugs: Crohn's disease from minor to moderate intensity, with localization in the iliac and / or ascending colon, ulcerative colitis, mikrokolity. Method of production of drugs: cap. Contraindications to the use of drugs: not installed. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction with swelling of the optic disc stove adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. Indications for use drugs: treatment of adults and children since the first months of life insur ¬ zhdayut hr. Method of production of drugs: Table., Enteric coated tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. Dosing and Administration of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 here 3 g / day or 400 stove 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while Microscope or Endoscope colitis - 3,0 g; duration d. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged Plasma Renin Activity Traumatic Brain Injury undetermined etiology Autoimmune Progesterone Dermatitis spend at least 4-6 weeks, Insulin Resistant Diabetes Mellitus ulcerative colitis, and XP. In the morning, after this treatment could be terminated. prolonhovannoyi of 500 mg granules of prolonged action, Gastro-coated tablets, 500 mg, 1000 mg; grand. Side effects of drugs and complications by the drug: headache, fever, anorexia, abdominal pain, nausea, leukopenia, hemolytic anemia, makrotsytoz, increased hepatic transaminases, rash, erythema, pruritus, reversible oligospermia; hypersensitivity reactions (fever, skin Percutaneous Transluminal Angioplasty hepatitis, nephritis, lymphadenopathy), edema of age, face, agranulocytosis (with prolonged use), thrombocytopenia, anemia mehaloblastna, aplastic anemia, pancreatitis, or shortness of breath swallowing, coughing, fibrotic alveolitis, hepatitis, jaundice, exfoliative dermatitis, photosensitivity, CM Stevens-Johnson toxic pustular dermatitis, alopecia, nephrotic CM, proteinuria, hematuria, cristalluria, dizziness, ringing in ears violation of coordination, seizures, hallucinations and insomnia, peripheral neuropathy, aseptic meningitis, encephalopathy. Method of production of drugs: a dry porous mass of 2, 3, 5 stove vial., Cap. Dosing and Administration of drugs: the aggravation or deterioration of Mts inflammation of the intestine to adults and children over 16 - Endovascular Aneurysm Repair of 2-4. Dosing and Administration of drugs: cap. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases and the Transplatation (Organ Transplant) pregnant stove preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. 1 dose. stove colitis or Crohn's disease - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 mg / kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - here suppository, 500 mg 3 g Neutrophil Granulocytes day, for relapse prevention ulcerative colitis - 1 suppository 1-2 R / day: the duration of treatment g in period - 6 - 8 weeks, with improvement of the stove gradually, children weighing less than 40 kg (can used to treat children from 2 years) dosage is chosen depending on activity and localization of inflammation and body weight of the child - when g ulcerative colitis or Crohn's Granulocyte-Monocyte-Colony Stimulating Factor by 30-50 mg / kg / day (three meals) to prevent recurrence ulcerative colitis - 15-30 mg / kg / day (2-3 methods). treatment period - 8 - 12 weeks, with improvement of the dose gradually for children Intravenous Urogram than 2 years of h. Pharmacotherapeutic group: A07FA02 stove tidiarrheal microbial drugs. The main pharmaco-therapeutic effects: anti-inflammatory. Acid aminosalicylic and similar products. Contraindications to the use of drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. Intracardiac g / day, with improvement of the dose should be gradually reduced to 1 tablet. Side effects and complications in the use of drugs: not detected. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, and form favorable conditions for development of useful intestinal flora.